These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Prime Minister Narendra Modi is flanked by French President Emmanuel Macron (left) and Rodolphe Saade, Chairman and CEO of the CMA CGM Group, during his visit to the Group Headquarters in ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Regular insulin, which is often used in pregnancy for the treatment of diabetes, has some drawbacks: it starts its action from 30 to 60 min after subcutaneous injection and it peaks too late (2-3 ...

As the CEO of RELEX Solutions, I’ve seen firsthand how critical it is to embed innovation into the culture of an organization. It’s not just about big breakthroughs or flashy new products—it ...